IMAC Holdings, Inc. (BACK)
OTCMKTS · Delayed Price · Currency is USD
0.1365
+0.0146 (11.96%)
At close: Jan 16, 2026
IMAC Holdings Market Cap
IMAC Holdings has a market cap or net worth of $516.82 thousand as of January 16, 2026. Its market cap has decreased by -78.87% in one year.
Market Cap
516.82K
Enterprise Value
4.30M
Revenue
22.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since February 13, 2019, IMAC Holdings's market cap has decreased from 26.65M to 516.82K, a decrease of -98.06%. That is a compound annual growth rate of -43.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 516.82K | -1.70% |
| Dec 31, 2025 | 525.73K | -79.44% |
| Dec 31, 2024 | 2.56M | 1.63% |
| Dec 29, 2023 | 2.52M | -61.20% |
| Dec 30, 2022 | 6.48M | -78.30% |
| Dec 31, 2021 | 29.88M | 64.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 831.36M |
| Glass House Brands | 739.20M |
| Elite Pharmaceuticals | 511.53M |
| Northwest Biotherapeutics | 446.47M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 335.01M |
| Silence Therapeutics | 262.62M |